Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats. (31st December 2023)
- Record Type:
- Journal Article
- Title:
- Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats. (31st December 2023)
- Main Title:
- Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats
- Authors:
- Hu, Bin
Tian, Tian
Li, Xin-Tao
Hao, Pei-Pei
Liu, Wei-Chao
Chen, Ying-Gui
Jiang, Tian-Yu
Chen, Pei-Shan
Cheng, Yi
Xue, Fu-Shan - Abstract:
- ABSTRACT: Objectives: To observe the protective effects of dexmedetomidine (Dex) postconditioning on myocardial ischemia/reperfusion injury (IRI) and to explore its potential molecular mechanisms. Methods: One-hundred forty-seven male Sprague-Dawley rats were randomly divided into five groups receiving the different treatments: Sham, ischemia/reperfusion (I/R), Dex, Brusatol, Dex + Brusatol. By the in vivo rat model of myocardial IRI, cardioprotective effects of Dex postconditioning were evaluated by assessing serum CK-MB and cTnI levels, myocardial HE and Tunel staining and infarct size. Furthermore, the oxidative stress-related markers including intracellular ROS level, myocardial tissue MDA level, SOD and GSH-PX activities were determined. Results: Dex postconditioning significantly alleviated myocardial IRI, decreased intracellular ROS and myocardial tissue MDA level, increased SOD and GSH-PX activities. Dex postconditioning significantly up-regulated myocardial expression of Bcl-2, down-regulated Bax and cleaved caspase-3 and decreased cardiomyocyte apoptosis rate. furthermores, Dex postconditioning promoted Nrf2 nuclear translocation, increased myocardial expression of Sirt3 and SOD2 and decreased Ac-SOD2. However, brusatol reversed cardioprotective benefits of Dex postconditioning, significantly decreased Dex-induced Nrf2 nuclear translocation and reduced myocardial expression of Sirt3 and SOD2. Conclusions: Dex postconditioning can alleviate myocardial IRI byABSTRACT: Objectives: To observe the protective effects of dexmedetomidine (Dex) postconditioning on myocardial ischemia/reperfusion injury (IRI) and to explore its potential molecular mechanisms. Methods: One-hundred forty-seven male Sprague-Dawley rats were randomly divided into five groups receiving the different treatments: Sham, ischemia/reperfusion (I/R), Dex, Brusatol, Dex + Brusatol. By the in vivo rat model of myocardial IRI, cardioprotective effects of Dex postconditioning were evaluated by assessing serum CK-MB and cTnI levels, myocardial HE and Tunel staining and infarct size. Furthermore, the oxidative stress-related markers including intracellular ROS level, myocardial tissue MDA level, SOD and GSH-PX activities were determined. Results: Dex postconditioning significantly alleviated myocardial IRI, decreased intracellular ROS and myocardial tissue MDA level, increased SOD and GSH-PX activities. Dex postconditioning significantly up-regulated myocardial expression of Bcl-2, down-regulated Bax and cleaved caspase-3 and decreased cardiomyocyte apoptosis rate. furthermores, Dex postconditioning promoted Nrf2 nuclear translocation, increased myocardial expression of Sirt3 and SOD2 and decreased Ac-SOD2. However, brusatol reversed cardioprotective benefits of Dex postconditioning, significantly decreased Dex-induced Nrf2 nuclear translocation and reduced myocardial expression of Sirt3 and SOD2. Conclusions: Dex postconditioning can alleviate myocardial IRI by suppressing oxidative stress and apoptosis, and these beneficial effects are at least partly mediated by activating the Nrf2/Sirt3/SOD2 signaling pathway. … (more)
- Is Part Of:
- Redox report. Volume 28:Number 1(2023)
- Journal:
- Redox report
- Issue:
- Volume 28:Number 1(2023)
- Issue Display:
- Volume 28, Issue 1 (2023)
- Year:
- 2023
- Volume:
- 28
- Issue:
- 1
- Issue Sort Value:
- 2023-0028-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-12-31
- Subjects:
- Dexmedetomidine -- myocardial ischemia/reperfusion injury -- oxidative stress -- apoptosis -- Nrf2/Sirt3/SOD2 signaling pathway
Free radicals (Chemistry) -- Pathophysiology -- Periodicals
Oxidation, Physiological -- Periodicals
541.224 - Journal URLs:
- http://www.ingentaconnect.com/content/maney/rer ↗
http://maneypublishing.com/ ↗ - DOI:
- 10.1080/13510002.2022.2158526 ↗
- Languages:
- English
- ISSNs:
- 1351-0002
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25712.xml